See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2020_AILERON_THERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001420565')"} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 19,550,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 295,000 |
3 | remainder_Assets | 6,628,000 |
4 | LiabilitiesCurrent | 5,839,000 |
5 | LiabilitiesNoncurrent | 4,586,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,293,000 |
9 | ResearchAndDevelopmentExpense | 17,663,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 587,000 |
13 | remainder_ComprehensiveNetIncome | 12,000 |
yvar | yval | |
---|---|---|
0 | Assets | 26,473,000 |
1 | Liabilities | 10,425,000 |
2 | Expenses | 29,956,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 16,048,000 |
5 | NetIncome | -29,369,000 |
6 | ComprehensiveNetIncome | -29,363,000 |
7 | BaseVar | 33,726,500 |
8 | EconomicCapitalRatio | -0.0954 |